Showing 1,621 - 1,640 results of 1,975 for search '"Research and Development"', query time: 0.14s Refine Results
  1. 1621
  2. 1622

    Profiling Near-surface Winds on Mars Using Attitude Data from Mars 2020 Ingenuity by Brian Jackson, Lori Fenton, Travis Brown, Asier Munguira, German Martinez, Claire Newman, Daniel Viúdez-Moreiras, Matthew Golombek, Ralph Lorenz, Mark D. Paton, Dylan Conway

    Published 2025-01-01
    “…In any case, the work here provides a foundation for exploration of planetary boundary layers using drones and suggests important future avenues for research and development.…”
    Get full text
    Article
  3. 1623

    Phytomedicinal armamentarium: A review of inula racemosa-derived alantolactones and isoalantolactones in anticancer therapy by Joshi Gaurav Santoshrao, Smriti Jamwal, Rakesh Kumar, Ekta Bisht, Bisen Harsh Krishnakumar, Shreya Katoch, R.K. Asrani

    Published 2025-02-01
    “…Their diverse mechanisms of action and minimal side effects position them as candidates for further research and development. Future studies should focus on clinical trials to establish their efficacy and safety in humans, paving the way for new cancer therapies.…”
    Get full text
    Article
  4. 1624
  5. 1625
  6. 1626
  7. 1627
  8. 1628

    Reflections by a member of the Editorial Board by Kevin T. Smith

    Published 2021-12-01
    “…We see the journal as a tool to support research and development of specific technologies, as well as to develop common terminology. …”
    Get full text
    Article
  9. 1629
  10. 1630
  11. 1631

    Connotation, research status, and development directions of clean coal geology in China by Yuegang TANG, Shaoqing WANG, Xiaoshuai WANG, Xin GUO, Yafeng WANG, Liping XUE, Harold H. Schobert

    Published 2025-01-01
    “…In the next decade, important research and development directions will include the spatiotemporal distribution of clean coals; the green, intelligent, quality-based combined production of paragenetic and associated minerals like coal gas; clean coal gasification; coal-based novel materials; underground coal-to-chemicals, and ecological restoration. …”
    Get full text
    Article
  12. 1632
  13. 1633
  14. 1634
  15. 1635
  16. 1636

    Comparison of brain activity metrics in Chinese and Russian students while perceiving information referencing self or others by Q. Si, J. Tian, V. A. Savostyanov, D. A. Lebedkin, A. V. Bocharov, A. N. Savostyanov

    Published 2025-01-01
    “…Neurocomputing technology is a field of interdisciplinary research and development widely applied in modern digital medicine. …”
    Get full text
    Article
  17. 1637
  18. 1638

    High prevalence of multidrug resistant and extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in the West reg... by Solomon Bayaba, Raspail Carrel Founou, Flaurant Thibau Tchouangueu, Brice Davy Dimani, Lethicia Danaëlle Mafo, Omer Aurelle Nkengkana, Luria Leslie Founou, Michel Noubom

    Published 2025-01-01
    “…Multidrug resistant and Extended-Spectrum β-Lactamase producing-Enterobacterales (ESBL-E) are pathogens of critical public health priority that urgently require the research and development of new drugs. This study aims to determine the prevalence and characterize the genes conferring resistance to β-lactams among Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections (UTIs) in the West region, Cameroon. …”
    Get full text
    Article
  19. 1639
  20. 1640

    ‘We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies by Sabine Vogler, Nina Zimmermann, Verena Knoll, Maximilian Salcher-Konrad, Friederike Windisch, Jaime Espin, Aukje K. Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman, Veronika J. Wirtz, Zaheer-Ud-Din Babar

    Published 2024-04-01
    “…Among the policy options that drew the most attention during the PPRI Conference were procurement with targeted instruments to achieve strategic objectives, innovative payment models such as different variants of managed-entry agreements, and new models to fund pharmaceutical research and development. Experiences on established policy options that are being newly introduced in several countries, such as price regulation, health technology assessment, evidence-based selection for reimbursement decisions and measures to enhance the uptake of biosimilar medicines were also shared. …”
    Get full text
    Article